Paper Details

  1. Home
  2. Paper Details

Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.

Author: FerrisS, FriedmanE, GeorgotasA, KrakowskiM, MannJ, McCarthyM, SiegelR

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

Phenelzine was effective in treating 65% of elderly depressed patients who were resistant to other treatments. Platelet MAO inhibition correlated with clinical response.
Paper Details　
Original Abstract of the Article :
Elderly depressed patients who met the research diagnostic criteria (RDC) for major depressive illness, resistant to other types of treatment, were treated with phenelzine, a nonselective monoamine oxidase (MAO) inhibitor, for a period of 2 to 7 weeks, following 2 weeks of placebo washout period. Do...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/6830930

データ提供：米国国立医学図書館（NLM）

MAO Inhibitors: A Light in the Desert of Depression

Depression can be a debilitating condition, and finding effective treatments can be challenging. This study investigates the effectiveness of phenelzine, a monoamine oxidase (MAO) inhibitor, in treating resistant geriatric depression. This research offers hope for individuals struggling with depression, particularly those who haven't responded to conventional treatments.

Phenelzine: A Potential Solution for Resistant Depression

The study demonstrates that phenelzine can effectively treat resistant geriatric depression. It provides evidence that MAO inhibitors could be a valuable treatment option for those who have not responded to other therapies.

Navigating the Desert of Depression

This research is like a well-stocked oasis in the desert of depression. It highlights the potential of MAO inhibitors in providing relief for individuals struggling with this challenging condition.

Dr.Camel's Conclusion

This research offers a beacon of hope in the desert of depression treatment. Phenelzine's effectiveness in treating resistant geriatric depression is a significant development.

Date :
  1. Date Completed 1983-05-27
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

6830930

DOI: Digital Object Identifier

6830930

Related Literature

Article Analysis
・Side Effects of phenelzine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.